SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignanciesStefan Hart, J W Wood|Leukemia|2011Cited by 198
Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaStefan Hart, J M Wood|Blood Cancer Journal|2011Cited by 109